The importance of conserved amino acid residues in p94 protease sub-domain IIb and the IS2 region for constitutive autolysis

FEBS Letters

Volumn 582, Issue 5, 2008, Pages 691-698

  Ono, Yasuko ^a   Hayashi, Chikako ^a,b   Doi, Naoko ^a,c   Tagami, Mai ^a   Sorimachi, Hiroyuki ^a,c  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Autolytic activity; Ca2+ dependence; Calpain; p94 calpain 3; Protease activity

Indexed keywords

CALCIUM ION; CALPAIN 3; PROTEINASE;

ANIMAL CELL; ARTICLE; AUTOLYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; STRUCTURE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; CALCIUM; CALPAIN; CERCOPITHECUS AETHIOPS; CONSERVED SEQUENCE; COS CELLS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUTANT PROTEINS; MUTATION; PEPTIDE HYDROLASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; SODIUM; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 39649087351     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.01.044     Document Type: Article

References (26)

1. Goll D.E., Thompson V.F., Li H., Wei W., and Cong J. The calpain system. Physiol. Rev. 83 (2003) 731-801
2. Suzuki K., Hata S., Kawabata Y., and Sorimachi H. Structure, activation, and biology of calpain. Diabetes 53 (2004) S12-S18
3. Sorimachi H., Ishiura S., and Suzuki K. Structure and physiological function of calpains. Biochem. J. 328 (1997) 721-732
4. 2+-dependent protease activity and a novel mode of enzyme activation. EMBO J. 18 (1999) 6880-6889
5. Strobl S., Fernandez-Catalan C., Braun M., Huber R., Masumoto H., Nakagawa K., Irie A., Sorimachi H., Bourenkow G., Bartunik H., Suzuki K., and Bode W. The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc. Natl. Acad. Sci. USA 97 (2000) 588-592
6. 2+ switch aligns the active site of calpain. Cell 108 (2002) 649-660
7. Sorimachi H., Toyama-Sorimachi N., Saido T.C., Kawasaki H., Sugita H., Miyasaka M., Arahata K., Ishiura S., and Suzuki K. Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J. Biol. Chem. 268 (1993) 10593-10605
8. Sorimachi H., Kinbara K., Kimura S., Takahashi M., Ishiura S., Sasagawa N., Sorimachi N., Shimada H., Tagawa K., Maruyama K., and Suzuki K. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J. Biol. Chem. 270 (1995) 31158-31162
9. Kinbara K., Sorimachi H., Ishiura S., and Suzuki K. Muscle-specific calpain, p94, interacts with the extreme C-terminal region of connectin, a unique region flanked by two immunoglobulin C2 motifs. Arch. Biochem. Biophys. 342 (1997) 99-107
10. Ono Y., Torii F., Ojima K., Doi N., Yoshioka K., Kawabata Y., Labeit D., Labeit S., Suzuki K., Abe K., Maeda T., and Sorimachi H. Suppressed disassembly of autolyzing p94/CAPN3 by N2A connectin/titin in a genetic reporter system. J. Biol. Chem. 281 (2006) 18519-18531
11. Ojima K., Ono Y., Doi N., Yoshioka K., Kawabata Y., Labeit S., and Sorimachi H. Myogenic stage, sarcomere length, and protease activity modulate localization of muscle-specific calpain. J. Biol. Chem. 282 (2007) 14493-14504
12. Richard I., Broux O., Allamand V., Fougerousse F., Chiannilkulchai N., Bourg N., Brenguier L., Devaud C., Pasturaud P., Roudaut C., Hillaire D., Passos-Bueno M.-R., Zats M., Tischfield J.A., Fardeau M., Jackson C.E., Cohen D., and Beckmann J.S. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 81 (1995) 27-40
13. Ono Y., Shimada H., Sorimachi H., Richard I., Saido T.C., Beckmann J.S., Ishiura S., and Suzuki K. Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J. Biol. Chem. 273 (1998) 17073-17078
14. Dasmahapatra B., DiDomenico B., Dwyer S., Ma J., Sadowski I., and Schwartz J. A genetic system for studying the activity of a proteolytic enzyme. Proc. Natl. Acad. Sci. USA 89 (1992) 4159-4162
15. Ono Y., Kakinuma K., Torii F., Irie A., Nakagawa K., Labeit S., Abe K., Suzuki K., and Sorimachi H. Possible regulation of the conventional calpain system by skeletal muscle-specific calpain, p94/calpain3. J. Biol. Chem. 279 (2004) 2761-2771
16. Ma H., Shih M., Hata I., Fukiage C., Azuma M., and Shearer T.R. Protein for Lp82 calpain is expressed and enzymatically active in young rat lens. Exp. Eye. Res. 67 (1998) 221-229
17. Fukiage C., Nakajima E., Ma H., Azuma M., and Shearer T.R. Characterization and regulation of lens-specific calpain Lp82. J. Biol. Chem. 277 (2002) 20678-20685
18. Herasse M., Ono Y., Fougerousse F., Kimura E., Stockholm D., Beley C., Montarras D., Pinset C., Sorimachi H., Suzuki K., Beckmann J.S., and Richard I. Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events. Mol. Cell. Biol. 19 (1999) 4047-4055
19. Mendoza I., Rubio F., Rodriguez-Navarro A., and Pardo J.M. The protein phosphatase calcineurin is essential for NaCl tolerance of Saccharomyces cerevisiae. J. Biol. Chem. 269 (1994) 8792-8796
20. 2+ transient activates calcineurin signaling to mediate ion homeostasis and salt tolerance of Saccharomyces cerevisiae. J. Biol. Chem. 277 (2002) 33075-33080
21. Moldoveanu T., Hosfield C.M., Lim D., Jia Z., and Davies P.L. Calpain silencing by a reversible intrinsic mechanism. Nat. Struct. Biol. 10 (2003) 371-378
22. 2+ dependency of calpain 3 (p94) activation. Biochemistry 45 (2006) 3714-3722
23. 2+ binding at two non-EF-hand sites. J. Biol. Chem. 279 (2004) 6106-6114
24. Arthur J.S., Gauthier S., and Elce J.S. Active site residues in m-calpain: identification by site-directed mutagenesis. FEBS Lett. 368 (1995) 397-400
25. Kawai H., Akaike M., Kunishige M., Inui T., Adachi K., Kimura C., Kawajiri M., Nishida Y., Endo I., Kashiwagi S., Nishino H., Fujiwara T., Okuno S., Roudaut C., Richard I., Beckmann J.S., Miyoshi K., and Matsumoto T. Clinical, pathological, and genetic features of limb-girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese families. Muscle Nerve 21 (1998) 1493-1501
26. Jia Z., Petrounevitch V., Wong A., Moldoveanu T., Davies P.L., Elce J.S., and Beckmann J.S. Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain. Biophys. J. 80 (2001) 2590-2596